At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
06118 AUSTAR
Not Yet Opened 12-11 13:00:09
0.960
+0.000
0.00%
High0.960Low0.960Vol3.00K
Open0.960D1 Closing0.960Amplitude0.00%
Mkt Cap492.48MTradable Cap492.08MTotal Shares513.00M
T/O2.88KT/O Rate0.00%Tradable Shares512.58M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
3.0% earnings growth over 5 years has not materialized into gains for Austar Lifesciences (HKG:6118) shareholders over that period
Simply Wall St.  ·  11-14
3.0% earnings growth over 5 years has not materialized into gains for Austar Lifesciences (HKG:6118) shareholders over that period
Austar Lifesciences (06118) Reports Unchanged Share Capital and Issued Shares for October 2025
Bulletin Express  ·  11-03
Austar Lifesciences (06118) Reports Unchanged Share Capital and Issued Shares for October 2025
Austar Lifesciences Limited's (HKG:6118) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
Simply Wall St.  ·  10-10
Austar Lifesciences Limited's (HKG:6118) Share Price Boosted 27% But Its Business Prospects Need A Lift Too
Hong Kong Stock Alert | AUSTAR (06118) Surges Over 54% in Late Trading as Austar Group Serves as Technology-Based Pharmaceutical Engineering Solutions Provider
Stock News  ·  10-09
Hong Kong Stock Alert | AUSTAR (06118) Surges Over 54% in Late Trading as Austar Group Serves as Technology-Based Pharmaceutical Engineering Solutions Provider
Austar Lifesciences' H1 Profit Jumps
MT Newswires Live  ·  08-27
Austar Lifesciences' H1 Profit Jumps
AUSTAR (06118) Reports Interim Results with Shareholders' Profit of RMB 24.999 Million, Up 325.37% YoY
Stock News  ·  08-26
AUSTAR (06118) Reports Interim Results with Shareholders' Profit of RMB 24.999 Million, Up 325.37% YoY
Austar Lifesciences H1 Pretax Profit RMB 30.3 Million
THOMSON REUTERS  ·  08-26
Austar Lifesciences H1 Pretax Profit RMB 30.3 Million
BRIEF-Austar Lifesciences Says Chen Yuewu Resigned As Executive Director
Reuters  ·  08-26
BRIEF-Austar Lifesciences Says Chen Yuewu Resigned As Executive Director
AUSTAR (06118): Bian Ce Appointed as Executive Director and Risk Management Committee Member
Stock News  ·  08-26
AUSTAR (06118): Bian Ce Appointed as Executive Director and Risk Management Committee Member
Austar Lifesciences Ltd - Chen Yuewu Resigned as Executive Director
THOMSON REUTERS  ·  08-26
Austar Lifesciences Ltd - Chen Yuewu Resigned as Executive Director
Austar Lifesciences Forecasts Boost in H1 Profit
MT Newswires Live  ·  07-31
Austar Lifesciences Forecasts Boost in H1 Profit
BRIEF-Austar Lifesciences Expects Profit Of RMB23-25 Million For HY
Reuters  ·  07-31
BRIEF-Austar Lifesciences Expects Profit Of RMB23-25 Million For HY
Austar Lifesciences Ltd. Anticipates Significant Profit Surge for First Half of 2025
Reuters  ·  07-31
Austar Lifesciences Ltd. Anticipates Significant Profit Surge for First Half of 2025
Austar Lifesciences - Sees Profit Growth Due to Exchange Gains, Others in Hy
THOMSON REUTERS  ·  07-31
Austar Lifesciences - Sees Profit Growth Due to Exchange Gains, Others in Hy

Introduction

Company Name.
AUSTAR
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Austar Lifesciences Ltd is a holding company that mainly engaged in providing integrated engineering solutions, and manufacturing and distributing pharmaceutical equipment and consumables. The Company operates six segments: Fluid and Bioprocess Systems segment, Cleanroom and Automation Control and Monitoring Systems segment, Powder and Solid Systems segment, GMP Compliance Services segment, Life Science Consumables segment, and Distribution and Agency of Pharmaceutical Equipment segment. The Company's products include clean utility equipment and systems, bioprocess equipment and systems, powder and solid equipment and systems, pharmaceutical process contamination control products, packaging and closed transport products, biosafety and laboratory animal equipment and consumables, and others.
Issue price:
--